SBSPON and urinary bladder cancer: We found that SBSPON downregulation in bladder cancer is closely associated with tumor clinical staging, pathological grade, regional lymph node metastases, and bladder cancer patients with low SBSPON expression have a worse prognosis survival prognosis (Fig. 1 and Table 1).